During the last session, 89bio Inc (NASDAQ:ETNB)’s traded shares were 1.01 million, with the beta value of the company hitting 1.02. At the end of the trading day, the stock’s price was $8.25, reflecting an intraday loss of -3.85% or -$0.33. The 52-week high for the ETNB share is $22.93, that puts it down -177.94 from that peak though still a striking 20.36% gain since the share price plummeted to a 52-week low of $6.57. The company’s market capitalization is $785.56M, and the average trade volume was 1.28 million shares over the past three months.
89bio Inc (NASDAQ:ETNB) trade information
89bio Inc (ETNB) registered a -3.85% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.85% in intraday trading to $8.25, hitting a weekly high. The stock’s 5-day price performance is -7.09%, and it has moved by -26.34% in 30 days. Based on these gigs, the overall price performance for the year is -46.60%.
89bio Inc (ETNB) estimates and forecasts
Statistics show that 89bio Inc has underperformed its competitors in share price, compared to the industry in which it operates. 89bio Inc (ETNB) shares have gone up 17.52% during the last six months, with a year-to-date growth rate less than the industry average at -10.00% against 12.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -11.24%. While earnings are projected to return -2.97% in 2024, the next five years will return 11.00% per annum.
ETNB Dividends
89bio Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
